SCHE Performance — Schwab Emerging Markets Equity ETF
Data updated: 2026-07-24
SCHE returned +11.23% year to date and +30.77% over one year to May 2026. Annualised returns are +19.25% over 3 years and +5.42% over 5 years. The fund trailed its Emerging Markets Equity category average: $100 invested three years ago grew to $170, against $186 for the category, and to $131 over one year, against $149. Volatility over the past three years was 13.85% a year. In the 12 months to May 2026 the fund took in a net $267.3M, and assets reached $12.74B.
SCHE Growth of $100
What $100 invested in Schwab Emerging Markets Equity ETF grew to, compounded from monthly returns reported on SEC Form N-PORT, against the Emerging Markets Equity category average over the same months.
| Period | SCHE | Category average |
|---|---|---|
| 1 year (Jun 2025 – May 2026) | $131 | $149 |
| 3 years (Jun 2023 – May 2026) | $170 | $186 |
| 5 years (Jun 2021 – May 2026) | $130 | $145 |
| Since data start (Sep 2019 – May 2026) | $180 | $202 |
SCHE Trailing Returns
Total returns to May 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | +11.23% |
| 1 year | +30.77% |
| 3 years (annualised) | +19.25% |
| 5 years (annualised) | +5.42% |
SCHE Annual Returns
Calendar-year total returns of Schwab Emerging Markets Equity ETF, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–May) | +11.23% |
| 2025 | +25.86% |
| 2024 | +11.59% |
| 2023 | +7.95% |
| 2022 | −17.08% |
| 2021 | −0.72% |
| 2020 | +14.78% |
| 2019 (Sep–Dec) | +13.06% |
SCHE Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +5.8% | +2.5% | −10.0% | +10.0% | +3.5% | — | — | — | — | — | — | — |
| 2025 | +1.0% | +0.5% | +0.8% | +0.7% | +3.9% | +4.5% | +1.9% | +2.1% | +6.3% | +1.8% | −1.7% | +1.6% |
| 2024 | −3.6% | +4.2% | +1.7% | +1.7% | +1.0% | +2.8% | +0.6% | +1.5% | +8.2% | −4.2% | −2.7% | +0.6% |
| 2023 | +7.1% | −6.1% | +2.5% | −1.1% | −2.4% | +4.1% | +6.1% | −5.6% | −2.0% | −3.8% | +6.8% | +3.3% |
| 2022 | −0.4% | −3.7% | −1.3% | −5.2% | +0.2% | −5.0% | −1.0% | +1.0% | −10.5% | −4.2% | +14.0% | −0.8% |
| 2021 | +3.3% | +1.0% | −1.6% | +2.5% | +1.3% | +1.1% | −6.7% | +3.2% | −3.4% | +1.1% | −3.7% | +1.6% |
| 2020 | −4.6% | −5.0% | −16.4% | +9.3% | +0.9% | +7.3% | +8.9% | +2.1% | −1.9% | +2.4% | +8.1% | +6.0% |
| 2019 | — | — | — | — | — | — | — | — | +1.2% | +4.2% | +0.2% | +6.9% |
SCHE Risk
Risk measures from monthly returns over Jun 2023 – May 2026.
- 3-year volatility (annualised): 13.85%
- 3-year Sharpe ratio: 1.06 (vs 4.5% risk-free rate)
- Best month: +10.02% (Apr 2026)
- Worst month: −9.97% (Mar 2026)
SCHE Fund Flows
Monthly money in and out of Schwab Emerging Markets Equity ETF, from SEC Form N-PORT.
- 12-month net flow: $267.3M
- 12-month gross sales (incl. reinvestments): $307.4M
- Sales ÷ redemptions: 7.68×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| May 2026 | $0 | $0 | $0 |
| Apr 2026 | $0 | $0 | $0 |
| Mar 2026 | $0 | $40.0M | −$40.0M |
| Feb 2026 | $0 | $0 | $0 |
| Jan 2026 | $0 | $0 | $0 |
| Dec 2025 | $278.6M | $0 | $278.6M |
| Nov 2025 | $16.8M | $0 | $16.8M |
| Oct 2025 | $0 | $0 | $0 |
| Sep 2025 | $0 | $0 | $0 |
| Aug 2025 | $0 | $0 | $0 |
| Jul 2025 | $0 | $0 | $0 |
| Jun 2025 | $12.0M | $0 | $12.0M |
SCHE Assets Under Management
Net assets of Schwab Emerging Markets Equity ETF by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-05-31 | $12.74B |
| 2026-02-28 | $12.46B |
| 2025-11-30 | $11.35B |
| 2025-08-31 | $10.64B |
| 2025-05-31 | $9.79B |
| 2025-02-28 | $9.28B |
| 2024-11-30 | $9.16B |
| 2024-08-31 | $9.09B |
| 2024-05-31 | $8.74B |
| 2024-02-29 | $8.37B |
| 2023-11-30 | $8.38B |
| 2023-08-31 | $8.46B |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.